Low-dose Buprenorphine as a Modulator of Social Motivation in Schizophrenia

NCT05778591 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: Placebo
DRUG: Buprenorphine 0.15 MG [Belbuca]

Sponsor

University of California, Los Angeles